Top companies

ASIANPAINT - 2262.1 (0.08%) AXISBANK - 959.3 (-1.12%) BAJAJFINSV - 1743.3 (1.53%) BAJFINANCE - 7397.15 (1.45%) BHARTIARTL - 1631.75 (0.34%) BPCL - 277.6 (-0.93%) COALINDIA - 379.2 (-0.62%) HDFCBANK - 1666.05 (1.44%) HEROMOTOCO - 4055.7 (0.77%) HINDUNILVR - 2342.95 (0.1%) ICICIBANK - 1200.45 (0.36%) INDUSINDBK - 970.95 (1.09%) ITC - 437 (-0.13%) KOTAKBANK - 1917.5 (1.28%) MARUTI - 12020.35 (1.15%) ONGC - 264.05 (-0.66%) RELIANCE - 1277.1 (0.27%) SBIN - 753.45 (-0.74%) TATAMOTORS - 742.75 (-2.37%) TATASTEEL - 128.92 (-0.6%) TCS - 4156.6 (2.99%) TITAN - 3356.45 (0.09%) WIPRO - 309.1 (3.6%)
TRENDING #Railtel Corporation of India Ltd1 #ICICI Prudential Life Insurance Company Limited1 #PNB Housing Finance Limited1 #HDFC Bank Limited1
Growmudra
Sector: Airlines

InterGlobe Aviation Limited


4011.5   1.7 (0.04%)

As on 22 Jan, 2025 18:21 IST
Open 4030
LTP 4011.5
Previous Close 4009.8
Day High 4094.65
Day Low 3945
Volume 1055592

Peers

Company Name Price Change %Change Day High Day Low Prev.Close Volume
SpiceJet 0 0 0 0 0 0 0
Jet Airways 0 0 0 0 0 0 0
Global Vectra 0 0 0 0 0 0 0
Growmudra

Top Gainers

Company LTP Change Gain
WIPRO 309.1 10.75 3.6 %
TCS 4156.6 120.75 2.99 %
BAJAJFINSV 1743.3 26.3 1.53 %
BAJFINANCE 7397.15 105.5 1.45 %
HDFCBANK 1666.05 23.65 1.44 %

Top Losers

Company LTP Change Loss
TATAMOTORS 742.75 -18 -18 %
AXISBANK 959.3 -10.9 -10.9 %
BPCL 277.6 -2.6 -2.6 %
SBIN 753.45 -5.6 -5.6 %
ONGC 264.05 -1.75 -1.75 %
Growmudra

Latest News


By Debdeep Gupta  |  13 Jan, 2025

Crude sensitive stocks slump as Brent oil prices surge past $81; HPCL, IndiGo, BPCL slip upto 6%

Crude-sensitive stocks like those of oil marketers, airlines, and paint and tyre manufacturers, which are dependent on crude as a key input material, took a hit on January 13 following a rise in Brent oil prices.Brent crude prices surged past $81 per barrel, hitting a three-month high in early trade today. The rally was driven by expectations that expanded US sanctions on Russian oil producers and...


By Debdeep Gupta  |  12 Jun, 2024

Grow Mudra's Inside Edge: Indigo not so 6E, Fastest Finger strikes in IRB, TIL rights shares, Oriana's social media power, Wizardry of promoters

Twin engine supplyInterglobe Aviation’s ex-promoter Rakesh Gangwal periodically selling part of his stake has been a source of edginess for bulls in the stock. But when the current promoter joins the spree, bulls have more reason to look over their shoulder. The outlook for the sector may be rosy, but technical factors also have a role to play in stock price moves. Some big guns of Dalal Street ...


By Debdeep Gupta  |  10 Jun, 2024

Short Call: The everything rally, earnings picture, cushion for market; Indigo, Tata Motors, Dabur, Wipro in focus

All’s well that ends, the market seems to be saying, looking at the runaway rally over the past three sessions. On the day of the election results, investors fled fancied themes like capex and PSU and sought refuge in FMCG names. The mood has improved significantly since, and investors are now loading up on both defensive as well as market-fancied themes. The obsession with a stable government f...


By Debdeep Gupta  |  27 May, 2024

Short Call: Street tries to work out combinations of poll results, Indigo, Bikaji Foods in focus

Six more trading sessions to go before the market starts looking for a fresh set of triggers. Smart money may be already looking beyond the elections. In a report last week, Morgan Stanley said that it likes India in the emerging markets space alongside Korea and Taiwan, but did not mention election results. “We continue to focus on strength in earnings growth over the forecast horizon in India,...


By Debdeep Gupta  |  14 May, 2024

Grow Mudra's Inside Edge: Mugul’s Capital play, action hots up in Dr Reddy’s, Voltas bulls cool it, Indigo maintains altitude

Booster shotAn interesting tug of war playing out in Dr Reddy’s following the fourth quarter numbers. Massive volumes were seen in the ADRs on Friday, and on Monday too ADR volumes were higher than usual. Dr Reddy’s has been among the laggards in the pharma pack, and the near-term outlook remains cautious given continued price erosion in the US generic space and increased R&D spending. Price a...


Growmudra © 2025 all right reserved

Partner With Us